RT Journal Article
SR Electronic
T1 Modeling the emergence of vaccine-resistant variants with Gaussian convolution COVID-19: Could the wrong strategy ruin vaccine efficiency?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.07.21259916
DO 10.1101/2021.07.07.21259916
A1 Bongiorno, Christian
A1 Cagnol, John
YR 2021
UL http://medrxiv.org/content/early/2021/07/08/2021.07.07.21259916.abstract
AB The SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic, has been shown to mutate. In the absence of a vaccine, natural selection will favor variants with higher transmissibility rates. However, when a substantial portion of the population is vaccinated, natural selection will shift towards favoring variants that can resist the vaccine. These variants can therefore become dominant and even cancel out the benefit of the vaccine. This paper develops a compartmental model which simulates this phenomenon and shows how various vaccination strategies can lead to the emergence of vaccine-resistant variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementComputations were performed using HPC resources from the Mesocentre computing facility at CentraleSupélec and École Normale Supérieure Paris-Saclay, which is partly funded by the CNRS and the Région Ile-de-France.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode is freely available. https://github.com/cagnol/COVID-Variants